🇺🇸 FDA
Patent

US 8388933

Multimeric protein toxins to target cells having multiple identifying characteristics

granted A61KA61K38/00A61K47/665

Quick answer

US patent 8388933 (Multimeric protein toxins to target cells having multiple identifying characteristics) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61K47/665, A61P, A61P19/04